BTW, all commercial botulinum-toxin products of consequence are type-A toxins. Myobloc (originally developed by Elan and marketed by Solstice Neurosciences) is a type-B toxin, but its sales are negligible.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.